Membership is open to all those with an interest in the quality and integrity of scientific research and development and those working with, or interested in, Good Laboratory, Clinical or Manufacturing Practice regulations or Pharmacovigilance, be they from industry, government, academia or contract research and wherever in the world they are based.
Welcome to the RQA website
As an Association dedicated to informing and advancing its members, we provide status and visibility for individuals concerned with the quality of research in pharmaceuticals, agrochemicals, chemicals and medical devices. Since its beginnings in 1977, the Association has grown and developed to reflect regulatory changes, the impact of regulatory inspection and the changing structure and needs of industry. RQA's purpose is to drive quality and integrity in scientific research and development.
Click here to view our vision and mission statement.
2015 RQA ANNUAL CONFERENCE
The RQA 2015 Annual Conference will be held at the Queens Hotel, Leeds on the 11-13 November 2015.
We are pleased to announce that our 'paid for' webcasts have been upgraded so that they are viewable on desktop/laptop computers, mobile browsers and for download to iOS and Android tablets. Certificates will also be available on full viewing of the webcast. Anyone who has purchased either the EU Clinical Trial Regulation: Final Document or Clinical Investigator EU Clinical Trials Regulation webcasts will receive a new link to the new version. Details on how to download electronic material to keep on a device can be found here- Android and iPad.
Social Media: What it is and how to use it - Webcast
We have produced a webcast on Social Media which is available on YouTube. The webcast describes the social media areas RQA currently uses and how to sign up to these and their benefits.
Latest News Items
Safety monitoring of medicines: EMA to screen medical literature for 400 active substance groups
New service will improve safety monitoring of medicines and simplify pharmacovigilance activities for companies The European Medicines Agency (EMA) has published the list of active substances and a reference to the journals that will be covered by its new medical literature monitoring service.
MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015
Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This document provides MHRA guidance on GMP data integrity expectations for the pharmaceutical industry.